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Abstract
Mitochondrial dysfunction contributes to myriad monogenic and complex pathologies. To
understand the underlying mechanisms, it is essential to define the full complement of pro-
teins that modulate mitochondrial function. To identify such proteins, we performed a meta-
analysis of publicly available gene expression data. Gene co-expression analysis of a large
and heterogeneous compendium of microarray data nominated a sub-population of tran-
scripts that whilst highly correlated with known mitochondrial protein-encoding transcripts
(MPETs), are not themselves recognized as generating proteins either localized to the mito-
chondrion or pertinent to functions therein. To focus the analysis on a medically-important
condition with a strong yet incompletely understood mitochondrial component, candidates
were cross-referenced with an MPET-enriched module independently generated via genome-
wide co-expression network analysis of a human heart failure gene expression dataset. The
strongest uncharacterized candidate in the analysis was Leucine Rich Repeat Containing 2
(LRRC2). LRRC2 was found to be localized to the mitochondria in human cells and transcrip-
tionally-regulated by the mitochondrial master regulator Pgc-1α. We report that Lrrc2 tran-
script abundance correlates with that of β-MHC, a canonical marker of cardiac hypertrophy in
humans and experimentally demonstrated an elevation in Lrrc2 transcript in in vitro and in
vivo rodent models of cardiac hypertrophy as well as in patients with dilated cardiomyopathy.
RNAi-mediated Lrrc2 knockdown in a rat-derived cardiomyocyte cell line resulted in enhanced
expression of canonical hypertrophic biomarkers as well as increased mitochondrial mass in
the context of increased Pgc-1α expression. In conclusion, our meta-analysis represents a
simple yet powerful springboard for the nomination of putative mitochondrially-pertinent
PLOS ONE | DOI:10.1371/journal.pone.0170458 February 3, 2017 1 / 20
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: McDermott-Roe C, Leleu M, Rowe GC,
Palygin O, Bukowy JD, Kuo J, et al. (2017)
Transcriptome-wide co-expression analysis
identifies LRRC2 as a novel mediator of
mitochondrial and cardiac function. PLoS ONE 12
(2): e0170458. doi:10.1371/journal.pone.0170458
Editor: Manuel Portole´s, Hospital Universitari i
Politecnic La Fe, SPAIN
Received: August 24, 2016
Accepted: January 5, 2017
Published: February 3, 2017
Copyright: © 2017 McDermott-Roe et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This work was supported by NIH New
Innovator Award OD008396 (AMG). The funder
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
proteins relevant to cardiac function and enabled the identification of LRRC2 as a novel mito-
chondrially-relevant protein and regulator of the hypertrophic response.
Introduction
Mitochondria are highly abundant organelles, found in almost every eukaryotic cell, and are
best known for production of adenosine triphosphate via oxidative phosphorylation. However,
the functional remit of the mitochondrion extends far beyond this canonical role as the ‘power-
house of the cell’ [1]. Mitochondria regulate multiple essential facets of cellular metabolism and
physiology including synthesis, breakdown and interconversion of amino acids, maintenance
and modulation of ion gradients, and regulation of pyrimidine and heme biosynthesis [2]. Given
the diverse and essential nature of such processes, it follows that perturbations therein result in
varied and often severe phenotypic manifestations. Mitochondrial diseases (MD) aggregately
represent the most prevalent cause of inborn errors of metabolism and encompass a clinically
heterogenous group of multisystemic disorders—with symptoms including myopathy, encepha-
lopathy, lactic acidosis, neuropathy, liver failure, ataxia, deafness and optic atrophy—that result
from defective mitochondrial function [3]. Mitochondrial dysfunction is also a feature of many
common diseases including Alzheimer’s [4], Parkinson’s [5], hypertrophic cardiomyopathy [6],
and cancer [7]. Elucidating how mitochondrial dysfunction contributes to disease states, either
as the principal cause of monogenic disorders or as a compounding feature in complex disease,
will undoubtedly augment diagnostic success and therapeutic prospects. The stochastic nature of
mitochondrial disease (e.g., multiple modes of inheritance, variable age of onset and wide symp-
tom spectrum [8] and challenges associated with reverse-genetics approaches means functional
genomics, proteomics and forward genetics-based strategies have played an important role in
the discovery of disease-associated genes. Capturing the full complement of mitochondrial pro-
teins has been the focus of much effort for the last two decades [9] and mass spectrometry-based
methods have been especially useful in the shaping understanding of the mitochondrial prote-
ome [10, 11]. MitoCarta is a collection of approximately 1,100 proteins with experimental evi-
dence of mitochondrial localization and is the most expansive self-contained survey to date [10].
As well as highlighting the functional heterogeneity of the organelle, MitoCarta has enabled the
identification of multiple disease-causing genes [12–16]. In addition to the proteins reported in
the MitoCarta database and companion studies [17, 18], it is estimated that a substantial number,
perhaps several hundred, remain unassigned and efforts to fill this gap continue.
Left ventricular hypertrophy refers to a cardiac growth response triggered by increased
mechanical stress (e.g., pressure overload, valvular disease and hypertrophic cardiomyopathy)
and represents a major risk factor for heart failure and all-cause mortality [19]. Mitochondrial
activity impinges profoundly on cardiomyocyte function, which in turn modulates organ-level
physiology and performance. For example, angiotensin II-mediated production of reactive
oxygen species in cardiomyocytes occurs primarily in the mitochondrion and leads to a hyper-
trophic growth response [20] while deficiency of TFAM, a key regulator of mitochondrial
DNA maintenance and transcription, triggers a fuel preference switch from fatty acids to glu-
cose, reduces energetic competence, and eventuates in severe cardiomyopathy [21]. Addition-
ally, the adverse effects of certain environmental toxins (e.g., paraquat) and therapeutics (e.g.
doxorubicin) occur via impact on mitochondrial function [22, 23]. Left ventricular hypertro-
phy has a strong genetic component [24] but in contrast to more tractable physiological and
metabolic traits, genetic association studies in humans have been relatively ineffective in
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identifying loci that modulate heart size and heart failure susceptibility. Hence, identification
of the proteins and pathways that modulate heart mass and function has thus far drawn heavily
on integrative genomics- and forward genetics-based approaches in rodents [25–27].
In the present study, we used a co-expression-based strategy to nominate proteins of signifi-
cance to both mitochondrial and cardiomyocyte function. The premise of co-expression pro-
filing is that transcripts that produce functionally-related proteins are often subject to
common regulatory mechanisms and thus display concordant expression profiles across dif-
ferent samples [28]. Such guilt-by-association methods have previously been applied to identify
mitochondrial proteins [10–12] although most studies used relatively small datasets and most
genes identified exhibited readily obvious co-expression metrics. We posited that the burgeon-
ing quantity of mineable large-scale datasets readily obtainable from databases such as Gene
Expression Omnibus and ArrayExpress would permit identification of proteins with less overt
co-expression patterns or those whose transcripts were not interrogated via the array formats
used in previous studies. Using a two-phase transcriptional correlation meta-survey that
involved a large-scale mitochondrion-centric multi-tissue screen followed by a cardiac-focused
analysis, we generated a novel hypothesis regarding LRRC2, which was then experimentally-
confirmed as a novel mitochondrially-associated protein and mediator of the hypertrophic
response in cardiomyocytes. Mechanistically, our findings are suggestive of a role for LRRC2
as a dampener of mitochondrial biogenesis and a positive regulator of cardiac hypertrophy via
coordinated modulation of PGC-1α activity. This study further underscores the utility of unbi-
ased and transcriptome-wide methods for the nomination of disease-relevant proteins and
assigns a mitochondrially-associated function to a protein for which very little was previously
known.
Results
Gene co-expression analysis nominates a population of transcripts of
potential importance in mitochondrial function
A mitochondrion-centric co-expression network was generated by searching the CO-Regula-
tion Database (CORD) [29] for transcripts with expression signatures similar to those of bona
fide mitochondrial protein-encoding transcripts (MPETs) (Fig 1A). A total of 935 MPETs (S1
Table), which we refer to herein as ‘seeds’ since they were used to create the network, were
queried in this way. The network comprised ~18,000 unique transcripts and ~183,000 tran-
script-transcript interactions (at R>0.5) (S2 Table). For comparative value, co-expression net-
works for the nucleus, endoplasmic reticulum, golgi apparatus, and plasma membrane were
also generated using compartment-specific seed lists (S1A Fig and S1 Table). The extent of
intra-correlation inherent to each network was measured using an approach analogous to
gene set enrichment analysis (GSEA) [30]. For a given compartment, all network transcripts
were ordered by the number of correlations shared with other transcripts in the network and a
running sum was generated by descending the ordered list and assigning up-step and down-
step scores to seed and non-seed transcripts, respectively (see Methods). In each compartment,
many of the transcripts that shared most correlations were seeds as evident from the skewed
gene set enrichment profiles (Fig 1B and S1A Fig), supporting the notion that the expression
of spatially-congruent, functionally-related transcripts is coordinately-regulated. Using the
same ordered lists, cumulative distribution analyses was conducted and revealed that the mito-
chondrial population, with half its seed population in the top 13% of its rank list, compared
with 24% (nucleus), 31% (plasma membrane), 35% (endoplasmic reticulum), and 38% (golgi
apparatus), to be the most intra-correlated (Fig 1C and 1D and S1B Fig). The mitochondrial
data was next explored in more depth. Given that ~1,500 of the estimated 23,000 protein-
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Fig 1. Construction of a mitochondrion-centric multi-tissue gene co-expression network. A, 935 bona fide MPETs [10] were systematically queried
using the CO-Regulation Database (CORD) to identify transcripts with similar expression signatures. The resulting correlate lists were merged to create a
network where nodes denote transcripts and edges join transcripts with concordant expression signatures. For any node, the extent of centrality in the
network correlates with increasing connectivity. For ease of viewing, only transcripts that correlate at R0.8 are displayed. B, Individual correlate lists derived
from CORD were concatenated to generate a ranked master list where rank is based on the number of times a given transcript was present across all
daughter lists. A running-sum (Enrichment Score) was then generated by descending the list and assigning a positive score (up-step) when a transcript was a
seed and a negative score (down-step) when it was not. The barcode denotes positions in ranked list of the seed population. C, Cumulative distribution
analysis of the ranked master list from B to quantify the extent of network intra-correlation, expressed as the percentage of the list containing half the seed
population, reveals half of the seeds used to build the network were present in the top 13% of the ranked transcript list (seed50 = 13%). D, Comparison of
seed50 values across all six major cell compartments following CORD-based network analysis. E, Data from B (mitochondrion) showing the maximum
Enrichment Score (Max ES, ~1,400) and resulting leading edge (LE). The red lines denote the ESs calculated following 1000 random walks. F, Distribution of
Pgc-1α-responsive transcripts within and beyond the LE sub-set. Matrix displays the number of transcripts within (+) and outside (-) the LE, regulated (+) or
not (-) by Pgc-1α and the bar chart displays relative abundance. G, Distribution of proteins not documented as being mitochondrially-localised but which
LRRC2 regulates mitochondrial function and cardiac hypertrophy
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coding genes in the human genome produce mitochondrial proteins [31], we posited that
chance alone would result in an approximate 7% (1,500/23,000) representation of MPETs in
any given seed’s correlate list. By comparing this by chance value to the actual quantities, we
found that 762 (>80%) of the 935 mitochondrial seeds correlate with a greater number of
MPETs than would be expected by chance alone (FET P<0.0001) (S2A Fig). Of note, nuclear-
encoded mitochondrial ribosomal protein-encoding transcripts featured prominently amongst
the most highly correlated seeds (S2B Fig and S2 Table) in keeping with the phenomenon that
network hub genes tend to encode proteins with transcriptional and/or translational proper-
ties due to their ‘control’ over other network genes [32, 33]. It also suggests a synchronicity
between the nuclear and mitochondrial genomes and as noted elsewhere, that regulation of
gene expression from the latter is modulated more via altered translational flux than transcrip-
tional [34, 35]. Next, a high-priority sub-population was nominated for further examination.
From the enrichment analysis, we defined a leading edge (LE) sub-set of transcripts (see Meth-
ods), the majority of which have not previously been linked to mitochondrial function (Fig 1E
and S3 Table). Given the high degree of intra-correlation and hence MPET representation in
the LE, it follows that it should be enriched with transcripts whose expression levels are modu-
lated by Peroxisome proliferator-activated receptor gamma coactivator-1alpha (Pgc-1α),
widely recognized as the master regulator of mitochondrial function [36–38]. By cross-
referencing the LE with an independently-derived list of Pgc-1α-responsive genes [39], we
found, as anticipated, that the LE contained relatively more transcripts regulated by Pgc-1α
(results not shown). Crucially, this enrichment persisted following removal of the seed sub-
population (Fig 1F and S4 Table) (Chi-square P<0.001). Next, we reasoned–given the physical
compartmentalization afforded by the mitochondrion–that if the LE is indeed enriched for
novel MPETs, then the cognate proteins would be inclined to interact with known mitochon-
drial proteins rather than non-mitochondrial proteins. When all ~750,000 protein-protein
interactions from the BioGrid database [40] were recovered and filtered as to retain only those
interaction events (20,955) in which one of the two proteins was a MitoCarta protein (we
define these interactions as MC+/MC- where MC+ and MC- denote MitoCarta and non-Mito-
Carta proteins, respectively), we found preferential residence of the 5,616 MC- proteins in the
LE population (FET P<0.001) (Fig 1G and S5 Table). For added stringency, we imposed a
minimal number of interactions threshold and found that when MC- proteins that purportedly
bind>1,>2,>5, or>10 bona fide mitochondrial proteins were selectively retained, the repre-
sentation of these MC- proteins in the LE relative to outside the LE became increasingly pro-
nounced (S3A and S3B Fig and S6 Table). In summary, our meta-analysis revealed that
transcripts that generate mitochondrial proteins are more highly co-regulated than transcripts
that give rise to proteins destined for any other major cellular compartment. Moreover, the
prioritized transcript population derived from the mitochondria network was, even upon
removal of known MPETs, enriched for transcripts regulated by Pgc-1α and whose protein
products interact with mitochondrial proteins, suggesting the presence of overlooked mito-
chondrially-relevant proteins.
purportedly interact with known mitochondrial proteins, according to publicly accessible proteomics data, within and beyond the LE sub-set. Matrix displays
the number of proteins within (+) and outside (-) the LE, purported to interact with known mitochondrial proteins based on analysis of BioGRID protein-protein
interaction (PPI) data [40] and the bar chart displays relative abundance. MC+ and MC- denote MitoCarta and non-MitoCarta proteins, respectively. For
example, there were 574 transcripts in the LE whose protein products have not been documented to produce mitochondrial proteins but which have been
reported to interact with known mitochondrial proteins. The P values in F and G correspond to the result of a Chi-squared test and a Fisher Exact Test (FET),
respectively.
doi:10.1371/journal.pone.0170458.g001
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A heart failure-specific gene co-expression network nominates LRRC2
as a mediator of mitochondrial and cardiac function
Left ventricular hypertrophy is a risk factor for heart failure and all-cause mortality and can
result from inappropriate signaling and metabolic derangement at the level of the mitochon-
drion [36]. Hence, we next attempted to leverage our data for the nomination of genes
involved in cardiac remodeling in a mitochondrial manner. Weighted gene co-expression net-
work analysis (WGCNA) [41] was applied to a large publicly available microarray dataset
(GSE5406) derived from healthy, ischemic heart failure, and idiopathic human heart failure
sample [42]. We identified an MPET-enriched module which was present in all sample sub-
group networks (based on GO term enrichment (Mitochondria P<1x10-12) but strongest in a
network produced by concurrently processing all sub-groups (Fig 2A and 2B and S4 Fig).
Cross-reference of the prioritized population from the first CORD-based meta-analysis with
the MPET module described above identified 78 common transcripts. Given functionally-
related genes are often co-expressed [43], it was hypothesised that ontological descriptors asso-
ciated with transcripts that correlate with these recurrent candidates would represent a useful
proxy for indirectly inferring functionality (Fig 2C). Hence, transcripts that correlated with
each candidate were recovered using CORD and then probed for over-representation of perti-
nent KEGG terms (dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy
(HCM)). Twenty-four of the recurrent transcripts possessed such enrichment and Leucine
Rich Repeat Containing 2 (LRRC2) exhibited the most significant guilt-by-association with
both diseases (HCM P<10x10-14; DCM P<8x10-12) (Fig 2D).
LRRC2 is mitochondrially-localized, transcriptionally-regulated by Pgc-
1a, and regulates mitochondrial biogenesis
How, if at all, LRRC2 may interface with mitochondrial and cardiac function is unknown and
despite belonging to one of the most evolutionarily-conserved and functionally-important
protein families [45], remains understudied. A LRRC2-GFP chimeric protein was expressed in
HEK293 cells and was observed to associate with the mitochondria and to a lesser extent the
cytosol and nucleus (Fig 3A). In silico profiling of a 3,000bp sequence upstream of the tran-
scription start site in the human, rat and mouse gene revealed multiple Estrogen-related recep-
tor alpha (ERRα) binding sites (Fig 3B, top panel), suggestive of regulation by Pgc-1α and thus
a role in fundamental mitochondrial function. We experimentally assessed this finding by
over-expressing Pgc-1α in mouse C2C12 cells and rat H9c2 cells via adenovirus-mediated
gene transfer and found that doing so invoked upregulation of the Lrrc2 transcript (Fig 3B,
bottom left and Fig 3C). Pgc-1-mediated regulation of Lrrc2 was also explored in vivo using a
cardiac-specific inducible Pgc-1α/β double knockout mouse. Pgc-1α/β loss led to a marked
reduction in Lrrc2 transcript abundance (Fig 3B, bottom right panel and Fig 3D).
The cardiac functionality of Lrrc2 in the context of hypertrophic remodelling was next
investigated in more detail. A significant elevation in Lrrc2 mRNA was observed in neonatal
rat ventricular myocytes following treatment with endothelin-1 as well as in the myocardium
of mice and rats following thoracic aortic constriction (TAC)-induced cardiac hypertrophy,
indicating a potential role in maladaptive hypertrophic remodelling (Fig 4A). We also
observed a correlation in the human heart (left ventricle) between LRRC2 mRNA abundance
and that of MYH7 (R = 0.61), an established hypertrophic biomarker (Fig 4B, left panel). To
address a possible link to human disease, we queried LRRC2 expression in a left ventricle-
derived RNASeq dataset derived from dilated cardiomyopathy (n = 140) and healthy control
(n = 110) subjects and observed elevated LRRC2 transcript expression in the patient cohort
(Fig 4B, middle panel). In the light of these results, we postulated that variation in Lrrc2
LRRC2 regulates mitochondrial function and cardiac hypertrophy
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Fig 2. Weighted gene co-expression network analysis (WGCNA) of a human cardiac gene expression dataset and nomi-
nation of proteins potentially involved in mitochondrial and cardiac function. A, Dendrogram representation of the 27 transcript
modules derived from WGCNA of a human heart failure microarray dataset (comprising healthy (n = 16), ischemic heart failure (n = 86)
and idiopathic heart failure (n = 108) samples). Horizontal lines (branches) represent modules and vertical lines (leaves) represent
transcripts. Asterisk denotes an MPET-enriched (green) module. B, Green module from A where transcripts are represented as nodes
(size denotes matrix membership (see Methods)) and edges denote significant transcript-transcript correlations. C, Schema illustrating
candidate selection following CORD and WGCNA studies. Genes nominated by both analyses were re-processed with CORD to
recover co-expressed genes and KEGG terms associated with those genes. In this illustrative example, all genes that correlate with the
Recurrent gene apart from Gene b are linked to Hypertrophic Cardiomyopathy suggesting that the Recurrent gene may also be function-
ally linked. D, Scatter plot showing the sub-set of recurrent genes (24 of 78) that correlate with a disproportionately large number of
genes linked to Hypertrophic Cardiomyopathy (HCM) and Dilated Cardiomyopathy (DCM). X and Y axes denote the EASE scores (a
measure of ontological enrichment [44]), expressed as -log10 P values, corresponding to DCM and HCM KEGG terms, respectively.
Grey dashed lines denote the P0.05 EASE threshold.
doi:10.1371/journal.pone.0170458.g002
Fig 3. LRRC2 localizes to the mitochondria and is regulated by Pgc-1. A, HEK293 cells expressing a LRRC2-GFP fusion protein were incubated
with MitoTracker Red and then imaged via confocal microscopy (left). Chart displays signal co-occurrence (green, LRRC2; red, MitoTracker Red) along
the dashed line in unmerged images. Scale bar = 20μm. B, Approximate positions of potential ERRα binding sites in rat, mouse and human LRRC2
genes (top panel), Lrrc2 mRNA abundance in C2C12 and H9c2 cells following infection with either a GFP- or Pgc-1α-encoding adenovirus (bottom-left
panel), and Lrrc2 mRNA abundance in the cardiac-specific inducible Pgc-1α/β double-knockout (DKO) mouse 3 weeks post-tamoxifen (TX) treatment
(bottom-right panel). C, Transcript abundance of Lrrc2 and control transcripts (36b4, Tbp and Hprt) as well as Pgc-1α/β in C2C12 cells following adeno-
virus-mediated over-expression of Pgc-1α and Pgc-1α/β. D, Transcript abundance of Lrrc2 and control transcripts (36b4, Tbp and Hprt) as well as Pgc-
1α/β in hearts of cardiac-specific Pgc-1α/β double knockout (DKO) mice and Cre only control mice. All QPCR data are represented as means ± s.e.m and
are derived from three independent experiments. *, P0.05.
doi:10.1371/journal.pone.0170458.g003
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mRNA levels may be relevant to pathological hypertrophy–either as an initiating or buffering
event—and explored the effect of loss-of-function in cardiomyocytes. Transfection of H9c2 rat
cardiomyocytes with a Lrrc2-specific siRNA reduced mRNA abundance by>75% (data not
shown) and was concomitant with induction of canonical hypertrophy marker genes atrial
natriuretic peptide, brain natriuretic peptide, and endothelin-1 (Fig 4B, right panel), suggest-
ing that Lrrc2 loss-of-function may contribute to reactivation of the fetal gene program. We
next turned our attention to the mechanism through which Lrrc2 suppression initiates the
Fig 4. LRRC2 modulates mitochondrial and cardiomyocyte function. A, Lrrc2 mRNA abundance in PBS- and ET-1-treated neonatal rat ventricular
myocytes (left panel), and left ventricle of mouse (middle panel) and rat (right panel) 4 weeks post-aortic banding compared to sham-operated controls. B,
Correlation in gene expression between LRRC2 and hypertrophic biomarker MYH7 (β-MHC) in the human heart (left panel), covariate-corrected LRRC2
mRNA abundance in myocardial samples derived from dilated cardiomyopathy (DCM) patients (n = 97) and non-failing controls (n = 108) (middle panel) (P
value calculated via Wilcoxon rank sum test), and effect of Lrrc2 loss-of-function in H9c2 cells on expression of hypertrophic biomarkers Bnp, Anf, and Et-1
(right panel). C, Effect of siRNA-mediated Lrrc2 loss-of-function in H9c2 cells on the abundance of total (left panel) and functional (middle panel) mitochondrial
abundance, and mitochondrial protein-encoding transcript expression (right panel). All QPCR data are represented as means ± s.e.m and are derived from
three independent experiments. *, P0.05; **, P0.001.
doi:10.1371/journal.pone.0170458.g004
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pro-growth response and asked whether the hypertrophy coincident with its loss could be due
to modified mitochondrial function. No overt morphological difference in the mitochondrial
network was observed following Lrrc2 knockdown (S5 Fig) but a modest yet measurable
increase in gross and functional mitochondrial mass was noted, as evident from elevated Mito-
Tracker Green and TMRE uptake, respectively (Fig 4C, left and middle panels). Consistent
with Lrrc2 loss-of-function promoting mitochondrial biogenesis (as opposed to repressing
removal of damaged or older mitochondria), abundance of Pgc-1α transcript and several Pgc-
1α-regulated transcripts were elevated following RNAi-mediated Lrrc2 depletion (Fig 4C,
right panel). In light of the transcriptional activation of Lrrc2 by Pgc-1α and that repression of
Lrrc2 increased Pgc-1α expression, we speculated as to the existence of a Lrrc2-mediated, non-
canonical feedback mechanism that may blunt the ability of Pgc-1α to auto-activate and hence
measured Pgc-1α mRNA via QPCR following adenovirus (Ad)-mediated over-expression in
H9c2 cells in the presence or absence of Ad-mediated LRRC2 over-expression. Ad-Pgc-1α
alone induced ~2,000-fold increase in Pgc-1α transcript relative to Ad-GFP cells while co-
infection of Ad-Pgc-1α and Ad-Lrrc2 induced a ~300-fold increase in Pgc-1a transcript (S6
Fig). In sum, these data suggest that Lrrc2 localizes at least partially to the mitochondria and
functions to fine-tune cardiomyocyte growth through a mechanism involving Pgc-1α-depen-
dent modulation of mitochondrial abundance.
Discussion
The premise of co-expression analysis is that transcripts that correlate with a particular query
transcript have an increased likelihood of being functionally-related to that particular query
transcript. Certain gene classes are particularly well suited to co-expression-based analyses.
For example, many heat shock and chaperone protein-encoding genes exhibit coordinated
changes in expression following modulations in their upstream regulator HSF1 [46]. Similarly,
many nuclear genes that give rise to mitochondrial proteins are expressed in a coordinated
fashion due to a relatively finite collection of upstream regulators. By way of example, Peroxi-
some proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) regulates the
expression of 70% of the one hundred or so electron transport chain sub-unit (and ATP
synthase) genes as well as all eight enzymes in the Citric Acid cycle [38]. Such synchronicity
affords significant predictive power and has been exploited to identify multiple mitochondrial
protein-encoding genes [10, 12]. In this study, we used a predictive methodology based on
gene co-expression to nominate proteins relevant to mitochondrial function in the context of
the metabolic and signaling derangement associated with pathological cardiac hypertrophy.
We first conducted a lenient and inclusive correlation analysis to nominate novel mitochon-
drial protein-encoding transcripts (MPETs). This was accomplished by probing almost 10,000
publicly available datasets with the CORD database [29] for transcripts whose expression sig-
natures resemble those of bona fide MPETs. In the second phase of the study, a less agnostic
approach was adopted in that we asked if the phase one candidates could be rediscovered in a
disease-relevant setting. To accomplish this, we created a gene network from a human heart
gene expression dataset [42] via WGCNA and identified a module highly enriched in MPETs.
Leucine Rich Repeat Containing 2 (LRRC2) was among this recurrent population and attracted
interest on account of it correlating with transcripts associated with cardiac remodeling as well
as a general paucity of knowledge regarding its function. We found LRRC2 to be at least par-
tially localized to the mitochondrion and regulated by the mitochondrial master regulator
PGC-1α. As well as being elevated in modeled hypertrophic settings, we also observed paral-
leled expression between LRRC2 and MYH7, an established biomarker of heart failure, in
the human heart [47]. Moreover, Lrrc2 suppression in a cardiomyocyte cell line invoked
LRRC2 regulates mitochondrial function and cardiac hypertrophy
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transcriptional changes typically associated with pathological hypertrophy and a concomitant
elevation in mitochondrial mass in the context of increased Pgc-1α expression. These data
implicate a role for LRRC2 in the control of processes that dictate cardiomyocyte hypertrophy
and mitochondrial abundance. How, mechanistically, LRRC2 loss-of-function invokes an
increase in mitochondrial biogenesis is uncertain and requires further examination. In light of
the association between compensated cardiac hypertrophy and Pgc-1α-driven mitochondrial
biogenesis, it’s tempting to speculate that Lrrc2-mediated regulation of Pgc-1α could influence
the hypertrophic response. Defining how LRRC2 fits into this model warrants additional study
but one possibility, suggested by the regulatory interplay observed (i.e., that Pgc-1α overex-
pression and suppression leads to increased and decreased Lrrc2 expression, respectively and
that Lrrc2 loss-of function elevates Pgc-1α expression) is that a protein-protein interaction
between Lrrc2 and Pgc-1α may dampen the capacity of the latter to auto-regulate. Indeed,
when Pgc-1α was over-expressed in H9c2 cells in combination with Lrrc2, the increase in Pgc-
1α transcript abundance was far less than that observed when it was over-expressed alone.
Enhanced presence of such repressive signals may contribute to the gradual reduction in mito-
chondrial function observed in heart failure and type 2 diabetes [48–50], and hence represents
a rational target for therapeutic intervention.
As well as nominating hitherto mitochondrially-relevant proteins for the second phase of the
study, the prioritized population provided corroborative insight into the regulation of mitochon-
drial gene expression. Ribosomal protein-encoding transcripts were by class the most highly rep-
resented when the population was reanalyzed by gene set enrichment analysis. Regulators of
gene expression typically assume central, highly correlated positions in transcriptional networks
because of their capacity to alter expression levels of other network genes. That mitochondrial
ribosomal proteins, and not transcriptional regulators (e.g., DNA Polymerase gamma), were
highly represented indicates that modulations in flux at the level of translation exert greater con-
trol over expression than transcription and are consistent with previous findings that implied
pruning of the apparently surplus population of mtDNA-derived transcripts is the principal
mechanism through which protein abundance is modulated.
Our nominated population of mitochondrially-associated proteins is far larger than the
undiscovered mitochondrial protein population proposed by other studies. That said, extra-
mitochondrial localization of a protein and its relevance to mitochondrial function are not
mutually-exclusive properties [2, 3, 37, 51–53] and the shortfall in the molecular diagnosis of
suspected cases of mitochondrial disease [16] is likely due in part to extra-mitochondrial pro-
teins that influence facets of mitochondrial function. Hence, we envisage the protein popula-
tion nominated in this study as representing a useful starting point for additional candidate
gene- and screening-based investigations aimed at cataloging additional proteins and path-
ways that regulate mitochondrial function.
Materials and methods
Network studies
The Co-Regulation Database (CORD) [29] is a collection of over 9,000 microarray datasets
which enables identification of transcripts with expression profiles similar to a user-specified
query (or ‘seed’) transcript. Upon query, CORD returns a table comprising transcripts with
expression signatures which correlate (based on the Pearson correlation coefficient (R)) with
that of the seed. Of 1,127 known mitochondrial protein-encoding transcripts (MPETs) [10]
queried in this way, 935 yielded correlate lists. (The remaining 192 were not expressed highly
enough or represented in a sufficient quantity of datasets in CORD to generate correlate lists.)
All seed-correlate interactions (at R0.5) across all 935 correlate lists were imported into and
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visualized using Cytoscape. To generate co-expression networks for other sub-cellular com-
partments (nucleus, endoplasmic reticulum, golgi apparatus, and plasma membrane), all
human genes (Ensembl Human release 85) were firstly classified based on the sub-cellular
compartment occupied by their protein product using gene ontology (GO) Inferred from
Direct Assay (IDA) terms downloaded from Biomart. Co-expression networks for each com-
partment were then generated as described for the mitochondrion.
Weighted gene co-expression analysis (WGCNA) was carried out as previously described
[27] on dataset GSE5406 [42] using the R package [41]. Details of all steps and functions can
be found in the package guide (https://cran.r-project.org/web/packages/WGCNA/WGCNA.
pdf) and code pertaining to this analysis is obtainable upon request. Briefly, all samples (non-
failing controls (n = 16), ischemic heart failure (n = 86), and idiopathic heart failure (n = 108))
were RMA-normalized and assessed for outliers and missing data using the goodSamples-
Genes function. Gene modules were constructed using the blockwiseModules function with a
soft-thresholding power = 9 and the significance of module assignment for each gene was
determined from Student asymptotic p-values calculated using the corPvalueStudent function.
Finally, Gene Ontology analysis of each module was conducted using DAVID [54].
Transcripts co-nominated by CORD- and WGCNA-based studies were subjected to an
additional correlation-based guilt-by-association analysis as an indirect means to infer involve-
ment in pathological cardiac remodeling. This involved querying recurrent transcripts with
CORD. From the resulting gene lists, KEGG term P values (which correspond to EASE scores
[44], a measure of ontological enrichment) for dilated cardiomyopathy (hsa05414) and hyper-
trophic cardiomyopathy (map05410) were recovered where present. Focus was placed on tran-
scripts that correlated with a higher than expected quantity of transcripts with the aforesaid
KEGG terms (based on EASE score).
Statistical tests
For enrichment analysis, a Kolmogorov-Smirnov test [55] was carried out following CORD
analysis to calculate the degree to which seed transcripts were over-represented at the top of
each compartment’s master list following concatenation of individual correlate lists. As in
GSEA [30], each master list was ordered (by the number of times each transcript was observed
across all individual correlate lists) and a running sum was produced by assigning an up-step
score (
ffiffiffiffiffiffiffi
N  G
p
G ¼ 4:32) on encountering seed transcripts and a down-step score ( 
ffiffi
G
p
N  G ¼   0:23)
on encountering non-seed transcripts (N and G correspond to the total number of genes and
the number of seed genes, respectively). For the mitochondrial data, 1,000 random walks were
also carried out by randomly reassigning seed designations to the pre-ordered list and re-
deriving the running sum. All transcripts located at or before the running sum’s maximum
deviation from zero (the maximum Enrichment Score) were classified as leading edge (LE)
transcripts and retained for further analysis. Cumulative distribution of seed transcripts in
each compartment analysis was also conducted on the same ordered lists to define the portion
of each list containing half of the seed transcripts used to generate the network. The calculated
value (defined as seed50) enabled us to quantify the extent of intra-correlation inherent to each
compartment.
Enrichment of experimentally-demonstrated Pgc-1α-responsive genes [39] and genes that
give rise to proteins purported to interact with known mitochondrial proteins (predicted using
BioGRID [40] in the LE population was calculated using a 2x2 contingency table in Prism 7
(GraphPad) of format Outcome 1 and 2 (columns) versus Group 1 and 2 (rows). In both analy-
ses, Group 1 and Group 2 corresponded to LE and non-LE transcripts, respectively. To mea-
sure distribution of Pgc-1α-responsive genes, Outcome 1 and Outcome 2 corresponded to
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Pgc-1α-responsive genes and Pgc-1α-unresponsive genes, respectively. For analyzing the dis-
tribution of genes that give rise to proteins purported to interact with known mitochondrial
proteins, Outcome 1 and Outcome 2 corresponded to the quantity of MC- proteins within the
EZ that interact with MC+ proteins and the quantity of MC- proteins outside the EZ that inter-
act with MC+ proteins, respectively (where MC+ protein denotes a MitoCarta protein and
MC- denotes a non-MitoCarta protein).
Cloning strategies
A human LRRC2 cDNA-containing plasmid (pCMV-SPORT6) was obtained from the Dhar-
macon Mammalian Gene Collection (MGC). The ORF was amplified (5’-TACATGCTAGC
ACCATGGGACATAAAGTGGTTGTCTTC-3’ and 5’-TACATGCTAGCCCAAGTTGAAGGCTAA
AAGACACTTT-3’) using Kod DNA polymerase (EMD4Biosciences), digested with NheI and
cloned upstream of and in-frame with the EGFP cassette in a CAG-EGFP vector using stan-
dard methods. Plasmid DNA (1μg) containing correctly orientated and sequence-verified
LRRC2 coding sequence was transfected into HEK293 cells (200,000) via electroporation. Cells
were seeded in glass-bottomed 35mm cell culture dishes. Forty-eight hours post-transfection,
cells were incubated for 1 hour with MitoTracker Deep Red FM (100nM) before being rinsed
briefly with PBS and viewed at x40 magnification using a Nikon A1+ confocal microscope.
Mitochondrial localization was determined following image capture via analysis of the overlap
between GFP and MitoTracker signals.
Animal studies
The experiments were approved by the Medical College of Wisconsin and University of Ala-
bama at Birmingham Institutional Animal Care and Use Committee (IACUC) in accordance
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Ani-
mals were maintained on a 12 hour light/dark cycle with ad libitum access to standard rodent
chow and water.
Pgc-1-mediated regulation of Lrrc2
The Pgc-1α and Pgc-1β adenoviruses have been described elsewhere [56]. C2C12 and H9c2
cells were infected with the specified adenovirus at a multiplicity of infection of 10–30, and
mRNA expression was measured, as described above, 72 hours later. Inducible cardiac-specific
Pgc-1α/β knockout mice were generated by crossing the floxed Pgc-1α/β strain [57] with the
tamoxifen inducible Myh6-MerCreMer strain [58]. Inducible cardiac-specific Pgc-1α/β knock-
out and control (Myh6-MerCreMer) mice were injected with tamoxifen (50mg/kg/day) daily
for 5 days. Mice were sacrificed 2 weeks post-injection and hearts were harvested for RNA iso-
lation and expression analysis. All animal experiments were performed according to proce-
dures approved by the University of Alabama at Birmingham Institutional Animal Care and
Use Committee (IACUC). Animals were euthanized with an intraperitoneal overdose of pen-
tobarbital (200mg/kg), followed by cervical dislocation.
siRNA-mediated Lrrc2 knockdown
H9c2 cells (100,000 cells/well) were seeded in a 12-well plate. The following day, cultures
(n = 5) were transfected with either a Lrrc2-specific or a non-targeting scrambled control
siRNA (Origene). For a given transfection, 5μl DharmaFECT1 and 95μl opti-MEM (Invitro-
gen) were mixed in one tube whilst 2.5μl of the Lrrc2-targeting or control siRNA (20μM) was
mixed with 97.5μl opti-MEM in a second tube. Following a 5 minute incubation at room
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temperature, solutions were mixed and left at room temperature for a further 20 minutes.
After the allotted time, cells received 800μl fresh media (DMEM supplemented with 10% heat-
inactivated FBS and 1% penicillin/streptomycin) followed by the above transfection mixtures.
The final concentration of siRNA was 50nM. Knockdown efficacy was assessed via QPCR
(Forward: AGTGCACGAGTCAAGGACAG; Reverse: TTGAGGTGTGTCTGTTCCTTC) 2–3 days
post-transfection and was found to be at least 75%.
Measurement of mitochondrial content
Two days post-siRNA transfection, H9c2 cultures were either harvested for RNA isolation (see
below) or incubated with either MitoTracker Green (100nM) for 1 hour or Tetramethylrhoda-
mine Ethyl Ester Perchlorate (TMRE) (10nM) for 20 minutes, after which they were dispersed
with trypsin-EDTA, washed twice and resuspended in 0.5 ml PBS/FBS (1%) and analysed
using an Accuri C6 flow cytometer in the case of MitoTracker Green and an LSRII flow cytom-
eter in the case of TMRE. Following selection of viable, singlet cell events (~10,000) from each
sample, median fluorescence values of the Lrrc2 siRNA- (n = 5) and scrambled control- (n = 5)
transfected cultures were calculated and compared using FloJo.
RNA isolation and expression analysis
Total RNA was extracted using either the RNeasy Mini kit (Qiagen) in the case of cell cultures
or an adapted Trizol-based protocol in the case of tissue, as previously described [27]. For tran-
script analysis, total RNA (1μg) was reverse transcribed (iScript, Bio-Rad) and the resulting
cDNA subjected to quantitative PCR (QPCR) using the iCycler iQ (Bio-Rad) instrument with
gene-specific primers, all of which were assessed for linear efficiency and single amplicon for-
mation. Unless otherwise stated, three independent samples were amplified in duplicate per
group, and presented data is representative of three independent experiments. All data were
analyzed using the 2-ΔΔCT method [59].
Gene expression analysis in human myocardial biopsies
As previously described [60], total RNA from 107 control and 96 DCM hearts was extracted
using TRIzol reagent and RNA-seq libraries were created with the TruSeq RNA Sample Prepa-
ration Kit (Illumina). Barcoded cDNA fragments were sequenced on an Illumina HiSeq 2000
with 2 × 100 bp PE chemistry. Gene-level quantification was performed using htseq-count
[61] and genome assembly GCRh37. Gene counts were normalized using variance-stabiliza-
tion transformation (VST), part of the DESeq package [62], and log2 transformed.
DCM transcriptome profiling
We measured transcriptome-wide RNA levels in left ventricle biopsies of end-stage DCM
patients (n = 128) that were snap-frozen and stored in liquid nitrogen in a tissue bank at the
Royal Brompton and Harefield Hospitals NHS Foundation Trust. The diagnosis of non-
ischaemic DCM was confirmed from medical records, but more detailed clinical data is not
available. We prepared non-stranded, poly(A)-selected RNA libraries for sequencing using the
TruSeq RNA Sample Preparation Kit (Illumina) and sequenced on a HiSeq 2000 (Illumina)
using paired-end chemistry. RNA-seq reads were aligned to the human reference genome
GRCh37 using tophat version 1.4.1. Gene expression was quantified as reads per kilobase per
million sequenced (RPKM) using an annotation based on Gencode version 19.
LRRC2 regulates mitochondrial function and cardiac hypertrophy
PLOS ONE | DOI:10.1371/journal.pone.0170458 February 3, 2017 14 / 20
Supporting information
S1 Fig. Construction of gene co-expression networks for 5 major cellular organelles.
Organelle-specific gene lists (created by classifying the entire protein-coding complement of
the genome (Ensembl Human release 85) using Gene Ontology Inferred from Direct Assay
(IDA) descriptors recovered from Biomart) were queried using CORD to generate co-expres-
sion networks and ranked master lists as described in Methods. A, Enrichment analysis of
ranked master lists derived from each network. On descending each ranked list (in which tran-
scripts are ranked by the number of times they correlate at R0.5 with other seed transcripts),
up- and down-step scores were applied to seeds and non-seeds, respectively (see Methods).
The barcode denotes positions in ranked list of the seed population. ES, Enrichment score. B,
Cumulative distribution analysis of each compartment-specific ranked master list to quantify
the extent of network intra-correlation, reflected by the seed50 value (the proportion of the
ranked list containing half the seed population). A small seed50 value reflects high intra-corre-
lation between the seed genes and a larger seed50 value reflects low intra-correlation.
(PDF)
S2 Fig. Intra-correlation of mitochondrial network seed genes and enrichment of ribo-
somal protein-encoding transcripts. A, 7% (1,500 of 21,000) of the human genome comprises
mitochondrial protein-encoding genes. Hence, a randomly generated gene list will not contain
more than 7% mitochondrial protein-encoding genes. The scatter plot (each circle represents a
seed gene) reveals that the vast majority (>80%) of the seed genes used to create the mitochon-
drial network (Fig 1) are co-expressed (R>0.5) with more than 7% mitochondrial protein-
encoding genes. Horizontal line displays the 7% by chance threshold. Inset bar chart displays
the percentage of seeds that correlate with>7% (+) or7% (-) MPETs. B, Distribution of
transcripts known to generate mitochondrial ribosomal proteins was analyzed via enrichment
analysis. On descending the ranked list (in which transcripts are ranked by the number of
times they correlate at R0.5 with other seed transcripts), up- and down-step scores were
applied to transcripts producing ribosomal proteins and those not, respectively (see Methods).
The maximum enrichment score (100) was significantly greater than that obtained from 1000
random walks (shown in red).
(PDF)
S3 Fig. Prioritized transcript population is enriched for protein products that physically
interact with known mitochondrial proteins. A, Percentage of transcripts within and outside
the LE that generate proteins reported (in the BIOGRID database) to interact with1,2,
5, and10 known mitochondrial proteins. B, Relative abundance of MC- proteins (proteins
that are not annotated by MitoCarta as being mitochondrially-loacalized but which are
reported (in the BIOGRID database) to interact with known mitochondrial proteins) that
interact with1,2,5, and10 known mitochondrial proteins in the LE compared to out-
side the LE.
(PDF)
S4 Fig. Weighted gene co-expression network analysis (WGCNA) of individual sample
groups from dataset GSE5406. Networks were constructed using the three sub-groups (con-
trol samples only, idiopathic samples only and ischemic samples only) as well as all samples
simultaneously. In each case, horizontal lines (branches) represent modules and vertical lines
(leaves) represent transcripts. Asterisks and accompanying P values denote MPET-enriched
modules and Benjamini-corrected P values obtained via DAVID-based GO term analysis,
respectively.
(PDF)
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S5 Fig. Mitochondrial morphology is not altered by LRRC2 loss-of-function. H9c2 cells
transfected with either a control or LRRC2-specific siRNA were stained with Mitotracker
Green and DAPI before being imaged via confocal microscopy (x100). Representative images
demonstrate no overt alteration in the morphology of the mitochondrial network. Scale
bar = 20μm.
(PDF)
S6 Fig. LRRC2-mediated repression of Pgc-1α induction in H9c2 cardiomyocytes. H9c2
cells were infected with either a GFP adenovirus alone (1st bar), equal amounts of a GFP and
Pgc-1α adenovirus (2nd bar), equal amounts of a Pgc-1α and a LRRC2 adenovirus (3rd col-
umn), or equal amounts of a GFP and LRRC2 adenovirus (4th bar). RNA was isolated and sub-
jected to QPCR with Pgc-1α-specific primers capable of detecting transcript derived from the
adenovirus and the endogenous gene (and HPRT primers for normalization). Data are repre-
sented as mean ± s.e.m from three independent experiments. , P<0.05.
(PDF)
S1 Table. Classification of human genes into 5 major sub-cellular compartments using GO
IDA descriptors.
(XLSX)
S2 Table. Ranked master list tables derived from co-expression analysis for major sub-cel-
lular compartments.
(XLSX)
S3 Table. Delineation of the leading edge (LE) transcript population in the ranked list
derived from the mitochondrial network.
(XLSX)
S4 Table. Distribution of experimentally-proven PGC-1α-regulated transcripts within and
outside the LE population.
(XLSX)
S5 Table. Distribution of transcripts within and outside the LE population whose protein
products purportedly interact with bona fide mitochondrial proteins.
(XLSX)
S6 Table. Classification of proteins derived from LE transcripts based on how many bona
fide mitochondrial proteins they purportedly interact with.
(XLSX)
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